Debt to Equity Ratio Chart

View Debt to Equity Ratio for DGWPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 0.2339
March 31, 2026 0.1364
December 31, 2025 0.2491
September 30, 2025 0.196
June 30, 2025 0.2234
March 31, 2025 0.1762
December 31, 2024 0.2577
September 30, 2024 0.2057
June 30, 2024 0.2379
March 31, 2024 0.1996
December 31, 2023 0.3351
September 30, 2023 0.265
June 30, 2023 0.2983
March 31, 2023 0.2998
December 31, 2022 0.2746
September 30, 2022 0.1674
June 30, 2022 0.1634
March 31, 2022 0.1802
December 31, 2021 0.2762
September 30, 2021 0.1778
June 30, 2021 0.3322
March 31, 2021 0.2478
December 31, 2020 0.3589
September 30, 2020 0.1526
June 30, 2020 0.2914
Date Value
March 31, 2020 0.2199
December 31, 2019 0.3257
September 30, 2019 0.2128
June 30, 2019 0.3357
March 31, 2019 0.2019
December 31, 2018 0.2298
September 30, 2018 0.2151
June 30, 2018 0.2288
March 31, 2018 0.2227
December 31, 2017 0.2273
September 30, 2017 0.2288
June 30, 2017 0.2312
March 31, 2017 0.2353
December 31, 2016 0.2788
September 30, 2016 0.3452
June 30, 2016 0.3643
March 31, 2016 0.3776
December 31, 2015 0.3603
September 30, 2015 0.3406
June 30, 2015 0.3581
March 31, 2015 0.3372
December 31, 2014 0.3675
September 30, 2014 0.3691
June 30, 2014 0.4065
March 31, 2014 0.1133

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Ottobock SE & Co. KGaA 3.079
Abbott Laboratories 0.638
AngioDynamics, Inc. 0.0641
Alphatec Holdings, Inc. 52.37
AtriCure, Inc. 0.1437